Miguel A. Velasco-Perez

Malaga, AN 29010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis.

Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 23, 2026

Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.

Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 28, 2026

Identifying dynapenia using ventilatory parameters in patients with heart failure with preserved ejection fraction: cross-sectional analysis of the FUNNEL+ study.

Identifying dynapenia using ventilatory parameters in patients with heart failure with preserved ejection fraction: cross-sectional analysis of the FUNNEL+ study.

Journal: Revista clinica espanola

Published: July 08, 2025

Assessment of Long-Term Mild and Major Neurocognitive Disorders 48 Months After Cardiac Surgery.

Assessment of Long-Term Mild and Major Neurocognitive Disorders 48 Months After Cardiac Surgery.

Journal: International journal of geriatric psychiatry

Published: May 09, 2025

Efficacy and safety of once-daily oral semaglutide in patients with heart failure with preserved ejection fraction, type 2 diabetes and obesity: a real-world study.

Efficacy and safety of once-daily oral semaglutide in patients with heart failure with preserved ejection fraction, type 2 diabetes and obesity: a real-world study.

Journal: European journal of internal medicine

Published: March 09, 2025

Efficacy of once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes.

Efficacy of once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes.

Journal: Medicina clinica

Published: November 24, 2024

In-hospital linagliptin for management simplification and hypoglycemia reduction in very old patients with type 2 diabetes.

In-hospital linagliptin for management simplification and hypoglycemia reduction in very old patients with type 2 diabetes.

Journal: Medicina clinica

Published: July 19, 2024

The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.

The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.

Journal: Journal of clinical medicine

Published: February 20, 2024

Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

Journal: Revista espanola de cardiologia (English ed.)

Published: November 08, 2023

Effectiveness of a cardiac rehabilitation program on biomechanical, imaging, and physiological biomarkers in elderly patients with heart failure with preserved ejection fraction (HFpEF): FUNNEL + study protocol.

Effectiveness of a cardiac rehabilitation program on biomechanical, imaging, and physiological biomarkers in elderly patients with heart failure with preserved ejection fraction (HFpEF): FUNNEL + study protocol.

Journal: BMC cardiovascular disorders

Published: September 22, 2023

Remission of type 2 diabetes: A critical appraisal.

Remission of type 2 diabetes: A critical appraisal.

Journal: Frontiers in endocrinology

Published: December 16, 2022

Effects of a New Group of Antidiabetic Drugs in Metabolic Diseases.

Effects of a New Group of Antidiabetic Drugs in Metabolic Diseases.

Journal: Reviews in cardiovascular medicine

Published: August 17, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026